Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: Synthesis and immunological activity

Journal of Medicinal Chemistry

Volumn 44, Issue 14, 2001, Pages 2370-2373

  Marastoni, M ^a   Bazzaro, M ^a   Micheletti, F ^a   Gavioli, R ^a   Tomatis, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; PEPTIDE DERIVATIVE;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOTHERAPY; SYNTHESIS; TUMOR;

ANTIGENS, VIRAL; CELL LINE; EPITOPES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPESVIRUS 4, HUMAN; HLA-A2 ANTIGEN; HUMANS; HYDROLYSIS; NEOPLASMS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035811456     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm001136a     Document Type: Article

References (27)

1. Antigen recognition by class I-restricted T lymphocytes
2. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2
3. Epstein-Barr virus and human malignancies
4. High incidence of Epstein-Barr virus genomes in Hodgkin's disease
5. Epstein-Barr immunodeficiency, and B cell lymphoproliferation
6. Conserved CTL epitopes within EBV latent membrane protein 2: A potential target for CTL-based tumor therapy
7. A single specific amino acid residue in peptide antigens is sufficient to activate memory cytotoxic T lymphocytes; potential role of cross-reactive peptides in memory T cell maintenance
8. From peptides to peptidomimetics: Design of nonpeptide ligands for Major Histocompatibility proteins
9. Terminal modifications inhibit degradation of an immunogenic MART-1 (27-35) peptide: Implications for peptides vaccines
10. Rational design of nonnatural peptides as high-affinity ligands for the HLA-B2705 human leukocyte antigen
11. A structure-based approach to designing nonnatural peptides that can activate anti-melanoma cytotoxic T cells
12. Efficient binding of reduced peptide bond pseudopeptides to major histocompatibility complex class I molecule
13. Partially modified retro-inverso pseudopeptides as nonnatural ligands for the class I histocompatibility molecule HLA-A2
14. New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules
15. A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope
16. Protection against lymphocytic choriomeningitis virus induced by a reduced peptide bond analogue of the H-2Db-restricted CD8(+) T cell epitope GP33
17. Peptoids: A modular approach to drug discovery
18. A facile synthesis of chiral N-protected α-amino alcohols
19. Synthesis of chiral N-protected α-amino aldehydes by reduction of N-protected N-carboxyanhydrides (UNCAs)
20. Synthesis of 9-fluorenylmethyloxycarbonyl-protected N-alkyl amino acids by reduction of oxazolidinones
21. An improved method for anchoring of 9-fluorenyl-methoxycarbonyl-amino acids to 4-alkoxybenzyl alcohol resins
22. Solid-phase synthesis of peptoids using Fmoc-protected N-substituted glycine: The synthesis of (retro)-peptoids of Leu-enkephalin and substance
23. Synthesis of O-glycosylated tufsins by utilizing threonine derivatives containing an unprotected monosaccharide moiety
24. High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes
25. The antigenic identity of peptide-MHC complexes a comparison of the conformations of five viral peptides presented by HLA-A2
26. Selective amino acid substitution of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: Imlications for immunotherapy of Epstein-Barr virus associated malignancies
27. Multiple HLA All-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen4